705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)...

by Andrew Mackinnon, Jason Chen, Natalija Sotirovska, Susanne Steggerda, Francesco Parlati, Tony Huang, Weiqun Li, Winter Zhang, Yong Ma, Deepthi Bhupathi
Published 2020-11-01

PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells

by Nilsa Rivera-Del Valle, Shan Gao, Claudia P. Miller, Joy Fulbright, Carolina Gonzales, Mint Sirisawad, Susanne Steggerda, Jennifer Wheler, Sriram Balasubramanian, Joya Chandra
Published 2010-01-01